- Filed
- May 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · May 22, 2025 | 2.78M sh |
| Capex | FY 2025 · Mar 31, 2025 | $14K |
| Capex | FY 2025 · Mar 31, 2024 | $19K |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$8.26M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$6.65M |
| Operating Cash Flow restated | FY 2025 · Mar 31, 2024 | −$6.6M |
| Net Income | FY 2025 · Mar 31, 2025 | −$11.41M |
| Net Income | FY 2025 · Mar 31, 2024 | −$15.43M |
| Net Income | FY 2025 · Mar 31, 2024 | −$15.43M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $8.61M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $777K |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $1.78M |
| Current Assets | FY 2025 · Mar 31, 2024 | $9.39M |
| Total Assets | FY 2025 · Mar 31, 2024 | $9.41M |
| Eps Basic restated | FY 2025 · Mar 31, 2024 | −$14.82 |
| Sga Expense | FY 2025 · Mar 31, 2024 | $5.25M |
| Rd Expense | FY 2025 · Mar 31, 2024 | $2.23M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$12.03M |
| Revenue | FY 2025 · Mar 31, 2024 | $0 |
| Stockholders Equity | FY 2025 · Mar 31, 2023 | $644K |